Stocks that moved markets this week: UnitedHealth, Netflix, Eli Lilly, and more

The Score: Key stock movers of the week — UnitedHealth, Eli Lilly, Netflix, and others

Market reactions to earnings, policy decisions, and global trade disruptions

A turbulent week across U.S. markets saw significant stock movements as companies reported earnings, disclosed regulatory setbacks, and responded to shifting trade policies. From the healthcare sector to tech and transportation, investors faced a wave of mixed news that shaped share prices and sector sentiment.

Here are some of the stocks that defined the week.


UnitedHealth stuns Wall Street with a rare earnings miss

UnitedHealth Group shares plunged 22% on Thursday following a disappointing earnings report and a sharp cut to its 2025 outlook. The company cited unexpectedly high medical costs in its Medicare segment—a trend that has hit the broader insurance sector but had largely spared UnitedHealth until now.

The news triggered a ripple effect across healthcare stocks, dragging down the Dow Jones Industrial Average by 1.3%, as UnitedHealth carries significant weight in the price-weighted index.
 

UnitedHealth.png

Apple and tech peers rally after tariff relief

Apple and other personal tech manufacturers gained ground after the Trump administration issued tariff exemptions on a wide range of electronics imported from China. Announced late April 11, the move spared items such as smartphones, memory chips, and PCs from fresh import levies.

Apple shares rose 4.1% on Monday. Dell Technologies climbed 4%, and HP advanced 2.6%, as investors breathed a sigh of relief over potential supply chain cost pressures.


Eli Lilly surges on weight-loss drug trial success

Eli Lilly shares jumped 14.3% Thursday after positive trial results for its experimental weight-loss pill, orforglipron. The once-daily oral medication successfully helped patients with type 2 diabetes lower blood sugar—marking the first milestone in a series of planned studies.

The obesity drug market is projected to exceed $100 billion by the end of the decade. Eli Lilly, alongside Novo Nordisk, is viewed as a front-runner, especially after Pfizer announced it was halting development of its own candidate due to safety concerns.


Netflix sets sights on $1 trillion valuation

Netflix added 4.8% on Tuesday after The Wall Street Journal reported that the company is aiming to double revenue by 2030 and reach a $1 trillion market capitalization. The streaming giant, currently valued at over $400 billion, has grown by raising prices, tightening password sharing, and launching an advertising tier.

Late Thursday, Netflix also posted record quarterly profits. With markets closed Friday for Good Friday, the full investor reaction will play out in the days ahead.


Nvidia hit by export restrictions, shares fall

Chipmaker Nvidia saw its shares drop 6.9% Wednesday after disclosing a $5.5 billion charge related to new U.S. export controls. The Biden administration now requires licenses to export Nvidia’s H20 AI processors to China and other countries.

The restrictions also apply to rival AMD, further clouding the outlook for U.S. semiconductor firms. ASML, a key supplier of chip-making equipment, reported weak orders and warned of broader disruption from the trade conflict.

Nvidia.png

J.B. Hunt warns of freight slowdown

J.B. Hunt Transport Services posted an 8% decline in first-quarter net income, sending shares down 7.7% on Wednesday. The logistics company blamed slower demand from retail customers facing uncertainty over tariffs and economic policy.

The results represent the first major earnings report from the freight sector since President Trump unveiled new tariffs earlier this month. Industry analysts say the U.S. shipping market remains oversupplied and challenged by weak pricing.


Stay tuned to finance news on The Horizons Times for the latest market-moving news and in-depth analysis of stocks shaping the week ahead.

Prev Article
Capital One’s $35B acquisition of Discover gains regulatory approval
Next Article
Trump’s trade ambitions risk higher costs and weaker markets

Comments (0)

    Leave a Comment